CTET CI Dr Jacqui McGovern has been awarded a grant worth $299,171 over three years from the Kids’ Cancer Project. Her work will involve developing an osteosarcoma precision oncology workflow.
Osteosarcoma is the most common malignant bone tumour affecting children and adolescents. Importantly, clinical outcomes have not improved for decades, and bone tumours remain a leading cause of cancer-related death in adolescents.
Precision oncology has the potential to advance treatment options, yet its widespread application is hindered by complex methodologies.
Using state-of-the-art technologies to mimic the tumour microenvironment, this study aims to analyse drug responses to determine effective therapeutic options specific to the individual tumour. This will accelerate the translation of precision medicine from bench-to-bedside for childhood sarcoma patients.
Distinguished Professor Dietmar W. Hutmacher will also be an investigator on the project, together with industry partner organisation, Gelomics.